TY  - JOUR
AU  - Santoro, Francesco
AU  - Núñez-Gil, Ivan J
AU  - Vitale, Enrica
AU  - Viana-Llamas, María C
AU  - Romero, Rodolfo
AU  - Maroun Eid, Charbel
AU  - Feltes Guzman, Gisela
AU  - Becerra-Muñoz, Victor Manuel
AU  - Fernández Rozas, Inmaculada
AU  - Uribarri, Aitor
AU  - Alfonso-Rodriguez, Emilio
AU  - García Aguado, Marcos
AU  - Huang, Jia
AU  - Castro Mejía, Alex Fernando
AU  - Garcia Prieto, Juan Fortunato
AU  - Elola, Javier
AU  - Ugo, Fabrizio
AU  - Cerrato, Enrico
AU  - Signes-Costa, Jaime
AU  - Raposeiras Roubin, Sergio
AU  - Jativa Mendez, Jorge Luis
AU  - Espejo Paeres, Carolina
AU  - López Masjuan, Alvaro
AU  - Marin, Francisco
AU  - Guerra, Federico
AU  - El-Battrawy, Ibrahim
AU  - Cortese, Bernardo
AU  - Ramakrishna, Harish
AU  - Perez-Villacastín, Julian
AU  - Fernandez-Ortiz, Antonio
AU  - Brunetti, Natale Daniele
PY  - 2022
DO  - 10.1161/JAHA.121.024530
UR  - http://hdl.handle.net/10668/20200
T2  - Journal of the American Heart Association
AB  - Background COVID-19 is an infectious illness, featured by an increased risk of thromboembolism. However, no standard antithrombotic therapy is currently recommended for patients hospitalized with COVID-19. The aim of this study was to evaluate safety...
LA  - en
KW  - COVID‐19
KW  - anticoagulation
KW  - antiplatelet therapy
KW  - aspirin
KW  - prognosis
KW  - risk prediction
KW  - Anticoagulants
KW  - Aspirin
KW  - COVID-19
KW  - Cohort Studies
KW  - Humans
KW  - Propensity Score
KW  - Registries
KW  - Retrospective Studies
TI  - Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry.
TY  - research article
VL  - 11
ER  -